Explore 3 Stock Ideas & Industry Insights Download Free Report
Peninsula Energy Limited

PEN Details
Peninsula Energy Limited (ASX: PEN) wholly owns the Lance Uranium Projects in Wyoming, USA, transitioning from an alkaline in-situ recovery to a low pH in-situ recovery operation. This transition aims to achieve the operating performance and cost profile of global uranium production projects.

Results Performance for the Year Ended 30 June 2021 (FY21)

Source: Company Reports, Analysis by Kalkine Group
Quarterly activities report for the period ended 31 December 2021
Outlook
The company has started the evaluation of field demonstration data at the Lance project with an expected two-month period of data analysis and process design evaluation before commencing an update of capital and operating costs. Meanwhile, the permitting of the identified process enhancements is in progress.
Further, the company holds uranium concrete sale agreements with major utilities for around 5 million pounds U308 at an average pricing of US$53 to US$55 per pound. Additionally, PEN holds an overall U3O8 uranium concentrate purchase commitment amounting 0.45 million-pounds as of 31 December 2021. The portfolio of uranium concentrate sale and purchase agreements have secured a forecast net cash margin of US$8 million to US$9 million on uranium sales in CY2022.
Key Risks
The company is exposed to risks associated with the existing mineral resource estimates, which could slightly deviate from actual findings. Further, the company must follow the conditions included within the prescribed low pH permit and use the common pH mining method across the entire Ross Permit Area.
Valuation Methodology: EV/Sales Based Relative Valuation (Illustrative)

Stock Recommendation
The company has delivered a 6-month and one-year return of ~+31.25% and ~+100.00%, respectively.
The stock has been valued using an EV/Sales multiple based relative valuation (on an illustrative basis), and the target price so arrived reflects a fall of low double-digit (in % terms). In addition, a slight discount has been applied to EV/Sales Multiple (NTM) (Peer Average), considering the negative ROE in FY21 and decreased liquidity position in FY21 over FY20.
Considering the aforementioned factors, the current trading levels, and the associated business risks, we advise the investors to book profits. We give a “Sell” rating on the stock at the current market price of $0.225 per share as of 2nd March 2022 (Time: 11:25 AM (GMT+10), Sydney, Australia).
Technical Overview:
Daily price Chart

Source: REFINITIV, Note: Purple color line reflects Relative Strength Index (14-Period)
PEN is a part of the Global Green Energy Portfolio
Note 1: The reference data in this report has been partly sourced from REFINITIV.
Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.
Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.
Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!